User profiles for Daniel L Rolnik
 | Daniel RolnikMaternal-Fetal Medicine, Monash University Verified email at monash.edu Cited by 6779 |
[HTML][HTML] Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia
Background Preterm preeclampsia is an important cause of maternal and perinatal death
and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy …
and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy …
Pre-eclampsia
Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …
ASPRE trial: performance of screening for preterm pre‐eclampsia
Objective To examine the performance of screening for preterm and term pre‐eclampsia (PE)
in the study population participating in the ASPRE (Combined Multimarker Screening and …
in the study population participating in the ASPRE (Combined Multimarker Screening and …
Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG …
Objective To compare the performance of screening for pre‐eclampsia ( PE ) based on risk
factors from medical history, as recommended by NICE and ACOG , with the method …
factors from medical history, as recommended by NICE and ACOG , with the method …
Prevention of preeclampsia with aspirin
Preeclampsia is defined as hypertension arising after 20 weeks of gestational age with
proteinuria or other signs of end-organ damage and is an important cause of maternal and …
proteinuria or other signs of end-organ damage and is an important cause of maternal and …
Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
Objective To examine the performance of screening for early, preterm and term pre‐eclampsia
(PE) at 11–13 weeks' gestation by maternal factors and combinations of mean arterial …
(PE) at 11–13 weeks' gestation by maternal factors and combinations of mean arterial …
Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries
Preterm birth (PTB) is the leading cause of infant mortality worldwide. Changes in PTB rates,
ranging from −90% to +30%, were reported in many countries following early COVID-19 …
ranging from −90% to +30%, were reported in many countries following early COVID-19 …
Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis
…, H Diamandis, R Fradkin, AE Stewart, DL Rolnik… - The Lancet, 2021 - thelancet.com
Background Little evidence is available on the use of telehealth for antenatal care. In
response to the COVID-19 pandemic, we developed and implemented a new antenatal care …
response to the COVID-19 pandemic, we developed and implemented a new antenatal care …
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their …
Background The Combined Multimarker Screening and Randomized Patient Treatment with
Aspirin for Evidence-Based Preeclampsia Prevention trial demonstrated that in women who …
Aspirin for Evidence-Based Preeclampsia Prevention trial demonstrated that in women who …
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
Background The Aspirin for Evidence-Based Preeclampsia Prevention trial was a multicenter
study in women with singleton pregnancies. Screening was carried out at 11-13 weeks’ …
study in women with singleton pregnancies. Screening was carried out at 11-13 weeks’ …
